Opiant Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Opiant Pharmaceuticals, Inc. Earnings Date And Information
Opiant Pharmaceuticals, Inc. last posted its earnings results on Tuesday, March 21st, 2023. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $-2.46 by $2.57. The company had revenue of 173.87 M for the quarter and had revenue of 40.73 M for the year. Opiant Pharmaceuticals, Inc. has generated $1 earnings per share over the last year ($0.51 diluted earnings per share) and currently has a price-to-earnings ratio of 30.58. Opiant Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 3rd, 2022 based on prior year's report dates.
Opiant Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2022 | Q3 2022 | -$1.93 | $23.83 M | $173.87 M | ||
| 08/11/2022 | Q2 2022 | -$1.36 | -$2.31 | -0.95 | $10.53 M | $2.33 M |
| 05/10/2022 | Q1 2022 | -$0.91 | -$2.51 | -1.6 | $2.19 M | |
| 03/15/2022 | Q4 2021 | $0.01 | $0.17 | 0.16 | $13.04 M | |
| 11/12/2021 | Q3 2021 | $0.77 | $25.49 M | $14.04 M | ||
| 08/05/2021 | Q2 2021 | -$0.28 | $0.39 | 0.67 | $11.26 M | $9.31 M |
| 05/11/2021 | Q1 2021 | -$0.71 | -$0.66 | 0.05 | $4.33 M | |
| 03/04/2021 | Q4 2020 | $0.07 | -$0.16 | -0.23 | $8.34 M | |
| 11/12/2020 | Q3 2020 | -$0.21 | $0.17 | 0.38 | $22.24 M | $8.60 M |
| 08/06/2020 | Q2 2020 | -$0.24 | -$0.05 | 0.19 | $30.30 M | $6.26 M |
| 05/12/2020 | Q1 2020 | -$0.19 | -$0.40 | -0.21 | $4.20 M | |
| 03/04/2020 | Q4 2019 | -$2.13 | $0.27 | 2.4 | $7.22 M | |
| 11/12/2019 | Q3 2019 | -$0.09 | $2.64 | 2.73 | $942,989 | $20.49 M |
| 08/08/2019 | Q2 2019 | -$0.55 | $0.39 | 0.94 | $12.02 M | $6.69 M |
| 05/09/2019 | Q1 2019 | -$0.79 | -$0.44 | 0.35 | $3.83 M | |
| 03/21/2019 | Q4 2018 | -$0.13 | -$3.19 | -3.06 | $4.46 M | |
| 11/07/2018 | Q3 2018 | -$0.40 | -$0.32 | 0.08 | $5.46 M | $4.25 M |
| 08/09/2018 | Q2 2018 | -$1.07 | -$0.52 | 0.55 | $3.11 M | |
| 05/08/2018 | Q1 2018 | -$3.68 | $1.70 M | |||
| 12/04/2017 | Q3 2017 | -$2.77 | $22,000 |
Opiant Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Opiant Pharmaceuticals, Inc.'s earnings date?
Opiant Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 3rd, 2022 based off last year's report dates.
-
Did Opiant Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Opiant Pharmaceuticals, Inc. (:OPNT) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.46 by $2.57.
-
How can I listen to Opiant Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Opiant Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Opiant Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Opiant Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Opiant Pharmaceuticals, Inc. generate each year?
Opiant Pharmaceuticals, Inc. (:OPNT) has a recorded annual revenue of $40.73 M.
-
How much profit does Opiant Pharmaceuticals, Inc. generate each year?
Opiant Pharmaceuticals, Inc. (:OPNT) has a recorded net income of $40.73 M. Opiant Pharmaceuticals, Inc. has generated $0.68 earnings per share over the last four quarters.
-
What is Opiant Pharmaceuticals, Inc.'s price-to-earnings ratio?
Opiant Pharmaceuticals, Inc. (:OPNT) has a price-to-earnings ratio of 30.58 and price/earnings-to-growth ratio is 1.31.
